News
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
According to detailed studies by ICMR and the National Centre for Disease Control (NCDC), the vaccines administered in India ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
In a 3-0 decision, the 2nd U.S. Circuit Court of Appeals found disputed issues over the sincerity of Jeanette Diaz's ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...
A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results